CN113736923B - Primer and kit for real-time fluorescent quantitative PCR (polymerase chain reaction) detection of Chapparvovirus - Google Patents
Primer and kit for real-time fluorescent quantitative PCR (polymerase chain reaction) detection of Chapparvovirus Download PDFInfo
- Publication number
- CN113736923B CN113736923B CN202111202886.4A CN202111202886A CN113736923B CN 113736923 B CN113736923 B CN 113736923B CN 202111202886 A CN202111202886 A CN 202111202886A CN 113736923 B CN113736923 B CN 113736923B
- Authority
- CN
- China
- Prior art keywords
- real
- quantitative pcr
- primer
- fluorescent quantitative
- time fluorescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 38
- 238000001514 detection method Methods 0.000 title claims abstract description 20
- 241000476149 Chapparvovirus Species 0.000 title claims abstract description 14
- 238000003752 polymerase chain reaction Methods 0.000 title description 8
- 241000282326 Felis catus Species 0.000 claims abstract description 13
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 8
- 239000007850 fluorescent dye Substances 0.000 claims description 5
- 230000003321 amplification Effects 0.000 abstract description 9
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 239000012634 fragment Substances 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 22
- 239000013612 plasmid Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000701087 Felid alphaherpesvirus 1 Species 0.000 description 2
- 241000488444 Feline bocavirus Species 0.000 description 2
- 241000714201 Feline calicivirus Species 0.000 description 2
- 241000725579 Feline coronavirus Species 0.000 description 2
- 241000472154 Mamastrovirus 2 Species 0.000 description 2
- 241000701945 Parvoviridae Species 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000288673 Chiroptera Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 241000121256 Densovirinae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000655 Distemper Diseases 0.000 description 1
- 241000701925 Feline parvovirus Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000121250 Parvovirinae Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 101150024766 VP1 gene Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 244000062645 predators Species 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000012418 validation experiment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a primer and a kit for real-time fluorescence quantitative PCR detection of Chapparvovirus cat, belonging to the technical field of molecular biology, wherein the primer comprises an upstream primer and a downstream primer, the upstream primer has a sequence shown as SEQ ID No.1, and the downstream primer has a sequence shown as SEQ ID No. 2. The SYBR Green I real-time fluorescent quantitative PCR technology established by the invention can realize high-efficiency amplification of target fragments in a short time, the whole reaction is simple and rapid, the detection rate is high, the repeatability is good, the SYBR Green I real-time fluorescent quantitative PCR technology is suitable for being used under the condition of large sample size, the popularization capability is strong, and the establishment of the invention can fill the blank of related fields.
Description
Technical Field
The invention relates to the technical field of molecular biology, in particular to a primer and a kit for real-time fluorescent quantitative PCR detection of Chapparvovirus cat.
Background
Parvoviridae are icosahedral, membrane-free, single-stranded DNA viruses with a genome size of about 4-6 Kb. The international committee on virus taxonomy divides the parvoviridae into three subfamilies, namely Densovirinae, Hamaparvovirinae and Parvovirinae. FCPV belongs to the genus Chaphamapivovirus in the subfamily Hamaparvovirinae. Members of the genus Chaphamaparvovirus have been found to infect a variety of vertebrates, including rats, mice, bats, dogs, pigs, chickens, turkeys, and the like. FCPV has been reported to be associated with diarrhea in cats.
At present, methods for molecular epidemiological detection of new viruses include a PCR method and a real-time fluorescent quantitative PCR method. The fluorescent quantitative PCR method is based on the common PCR, a pair of specific primers is added in an amplification reaction system, and a specific fluorescent probe is added at the same time, so that the SYBR Green I-based real-time fluorescent quantitative PCR technology has the advantages of high specificity, strong sensitivity, good repeatability and the like, has an intuitive reaction result, and is widely used for virus detection. However, there is no report of the use of SYBR Green for the detection of FCPV at present.
Disclosure of Invention
The invention aims to provide a primer and a kit for real-time fluorescent quantitative PCR detection of Chapparvovirus cat, which are used for solving the problems in the prior art.
In order to achieve the purpose, the invention provides the following scheme:
the invention provides a primer for real-time fluorescent quantitative PCR detection of Chapparvovirus cat, which comprises an upstream primer and a downstream primer, wherein the upstream primer has a sequence shown as SEQ ID No.1, and the downstream primer has a sequence shown as SEQ ID No. 2.
The invention also provides application of the primer for the real-time fluorescence quantitative PCR detection of the cat Chapparvovirus, which is to use the primer for the real-time fluorescence quantitative PCR detection of the cat Chapparvovirus.
The invention also provides a real-time fluorescence quantitative PCR kit for the cat Chapparvovirus, which comprises the primer for the real-time fluorescence quantitative PCR detection of the cat Chapparvovirus.
Further, the real-time fluorescent quantitative PCR kit also comprises DNA fluorescent dye.
Further, the DNA fluorescent dye is SYBR Green I.
In the present invention, SYBR Green I based real-time fluorescent quantitative PCR was established to detect FCPV, which will subsequently also be used to evaluate clinical samples.
The SYBR Green I real-time fluorescent quantitative PCR technology established by the invention can realize high-efficiency amplification of target fragments in a short time, the whole reaction is simple and rapid, the detection rate is high, the repeatability is good, the SYBR Green I real-time fluorescent quantitative PCR technology is suitable for being used under the condition of large sample size, the popularization capability is strong, and the establishment of the invention can fill the blank of related fields.
The fluorescence quantitative PCR is to continuously monitor the intensity of a fluorescence model in the PCR reaction process to measure the amount of a specific product in real time, and accordingly deduces and monitors the initial toxic content of a pathological material, so that the method not only has the characteristic of high amplification efficiency of the conventional PCR technology, but also has the characteristics of high specificity, high sensitivity and accuracy of the spectral technology and the like, simultaneously avoids the steps of subsequent electrophoresis and the like, and reduces the errors caused by pollution and manual operation. And tests prove that the method has high sensitivity and specificity and good repeatability.
The invention discloses the following technical effects:
(1) the primer provided by the invention is adopted to detect a sample, and the sensitivity can reach 101Copy number/. mu.L, 100 times more sensitive than conventional PCR methods.
(2) The specificity is good, the feline astrovirus, feline bocavirus type 1, feline parvovirus, feline coronavirus, feline calicivirus and feline herpesvirus are simultaneously detected in the experiment, and the method does not react with other common viral diseases of cats and has good applicability.
(3) Simple operation and short detection time.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings needed in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings without creative efforts.
FIG. 1 is a standard curve of real-time fluorescent quantitative PCR method for FCPV;
FIG. 2 shows the specificity experiment result of real-time fluorescent quantitative PCR method for FCPV;
FIG. 3 shows the results of sensitivity experiments of real-time fluorescent quantitative PCR method for FCPV.
Detailed Description
Reference will now be made in detail to various exemplary embodiments of the invention, the detailed description should not be construed as limiting the invention but as a more detailed description of certain aspects, features and embodiments of the invention.
It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. Further, for numerical ranges in this disclosure, it is understood that each intervening value, between the upper and lower limit of that range, is also specifically disclosed. Every smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in a stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference herein for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the present disclosure without departing from the scope or spirit of the disclosure. Other embodiments will be apparent to those skilled in the art from consideration of the specification. The description and examples are intended to be illustrative only.
Example 1 validation experiment of real-time fluorescent quantitative PCR detection method for FCPV
1. Specific primers were designed against VP1 gene of FCPV (Carnivore chapparvorous 1 isolate VRI 849, complete genome sequence No. GenBank: MN 794869.1):
upstream primer (SEQ ID No. 1): 5'-GCGTATACCGTATGGGGTCA-3' are provided.
Downstream primer (SEQ ID No. 2): 5'-AGTCCCTGGGAATCTCCATC-3' are provided.
The upstream and downstream primers were synthesized by general-purpose company.
2. Strain
The FCPV used in the experiment was identified and stored in the laboratory. And the strain can also be obtained by obtaining the above sequence from NCBI and then synthesizing by ordinary biological methods commonly used in the art.
3. Extraction of viral nucleic acids
The virus genome is extracted from the collected samples according to the instructions of a Tiangen genome kit (Tiangen biotechnology limited), and then the virus genome is stored at the temperature of-20 ℃ for later use.
4. Construction of recombinant plasmids
4.1 connection
The purified DNA fragment was ligated into the pMD-19T vector using the TA cloning procedure. The ligation conditions were 16 ℃ for ligation for 3 h. The linking system is as follows: the gel recovered product was 4. mu. L, pMD-19T 1. mu.L, Solution I5. mu.L.
4.2 transformation
The ligation product was transformed into DH 5. alpha. competent cells by the following specific procedures:
(1) taking out DH5 alpha competent cells in advance, and placing the cells on ice to melt the cells fully;
(2) add 5. mu.L of ligation product to 50. mu.L of DH 5. alpha. competent cells;
(3) incubating at 4 ℃ for 30min, then carrying out water bath at 42 ℃ for 90s, and then quickly transferring ice to carry out ice bath for 150 s;
(4) adding 600 μ L of nonresistant LB culture medium preheated to 37 deg.C, and culturing at 37 deg.C with shaking table at 200rpm for 1-2 h;
(5) centrifuging at 6000rpm for 3min, discarding 500 μ L of supernatant, and reserving 100 μ L of liquid to fully resuspend bacterial precipitation;
(6) the resuspended liquid was aseptically spread on an ammonia-resistant solid medium and cultured overnight at 37 ℃.
4.3 plasmid extraction and sequencing
After overnight culture, a single colony in a solid medium was picked, placed in 5mL of LB medium with ampicillin resistance, and cultured at 37 ℃ for 12 hours with a shaker at 200 rpm. And meanwhile, carrying out PCR verification on the bacterial liquid, and carrying out plasmid extraction on the bacterial liquid identified as correct. The detailed steps for extracting plasmids are as follows:
(1) column equilibration step: adding 500 μ L of equilibrium liquid BL into the adsorption column, centrifuging at 12000rpm for 1min, and discarding the waste liquid;
(2) adding the bacterial liquid into a centrifugal tube, centrifuging at 12000rpm for 1min, and completely removing the supernatant;
(3) adding 250 mu L of solution P1 into the precipitate, and performing vortex oscillation to completely resuspend the precipitate;
(4) adding 250 μ L of solution P2 into the suspension in the previous step, and turning up and down for 6-8 times;
(5) adding 350 μ L of solution P3 into the suspension in the previous step, turning over for 6-8 times, and centrifuging at 12000rpm for 10 min;
(6) sucking out the supernatant to a filter column CS, and centrifuging at 12000rpm for 2 min;
(7) adding the centrifuged liquid into an adsorption column which finishes the column balancing step, centrifuging at 12000rpm for 45s, and discarding the waste liquid;
(8) adding 500 mu L PD into the adsorption column, centrifuging at 12000rpm for 45s, and discarding the waste liquid;
(9) add 600. mu.L PW to the adsorption column, centrifuge at 12000rpm for 45s, discard the waste:
(10) repeating the step (9);
(11) adding no liquid into the adsorption column, centrifuging at 12000rpm for 2min, and completely removing the liquid in the adsorption column;
(12) transferring the adsorption column into a new 1.5mL centrifuge tube, dropwise adding 50 mu L of eluent TB into the middle part of the adsorption column, standing at room temperature for 2min, and centrifuging at 12000rpm for 2 min;
(13) the obtained recombinant plasmid is put into the temperature of minus 20 ℃ for storage and standby, and meanwhile, part of the plasmid is extracted and sent to the biological (Shanghai) company Limited for sequencing verification.
Example 2 real-time fluorescent quantitative PCR reaction and Standard Curve plotting
The concentration of the recombinant plasmid was determined by a nucleic acid concentration meter, and the copy number of the recombinant plasmid was calculated to be 1.07X 1011copies/. mu.L. 10-fold serial dilutions of recombinant plasmids were used as templates on a CFX96 ™ real-time PCR detection System (Bio-Rad, Hercules, CA, USA)Line SYBR Green I assay. The system consisted of 10. mu.L SuperReal Premix Plus (Chinese Tiangen), 0.6. mu.L forward primer, 0.6. mu.L reverse primer, 1. mu.L template and 7.8. mu.L ddH2And (C) O. SYBR Green I conditions were 95 ℃ for 15min, then 95 ℃ for 10s and 60 ℃ for 30s, 40 cycles. The recombinant plasmid was diluted to 10 in a ten-fold gradient1And a standard curve is established, the abscissa represents the logarithm of the copy number of the plasmid, and the ordinate represents the Ct value. On the basis, a corresponding regression equation is obtained: y = -3.354x +34.612, R2The amplification efficiency was 1.000, 98.7%. The standard curve is shown in FIG. 1. And no primer dimer and non-specific amplification product appear in the amplification process, and the primer specificity of the established fluorescent quantitative PCR method is good.
Example 3 specificity, sensitivity and reproducibility assays
1. Experiment of specificity
The established method for implementing fluorescent quantitative PCR is adopted to amplify the nucleic acids of the FCPV positive standard, the feline astrovirus, the feline bocavirus type 1, the feline herpesvirus, the feline distemper virus, the feline coronavirus and the feline calicivirus, and negative control is established, the result is shown in figure 2, the negative is a straight line without change, and no specific amplification curve except the FCPV, which indicates that the method has good specificity.
2. Sensitivity test
10 of the ten-fold diluted recombinant plasmid8To 101As a template, the result of the fluorescent quantitative PCR amplification is shown in FIG. 3, and the lowest copy number detected by the method is 1.07X 101copies/μL。
3. Repeatability test
At 108,106,104,102The repetitive experiments of real-time fluorescent quantitative PCR were carried out using 4 copies of recombinant plasmids as templates, and the results are shown in Table 1. The variation coefficients are all less than 1% in the repeatability experiment, which shows that the method has good repeatability.
TABLE 1 real-time fluorescent quantitative PCR repeatability experiment
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Sequence listing
<110> agriculture university of Anhui
<120> primer and kit for real-time fluorescent quantitative PCR detection of cat Chapparvovirus
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
agtccctggg aatctccatc 20
Claims (4)
1. The primer for real-time fluorescent quantitative PCR detection of the Chapparvovirus cat is characterized by comprising an upstream primer and a downstream primer, wherein the upstream primer has a sequence shown as SEQ ID No.1, and the downstream primer has a sequence shown as SEQ ID No. 2.
2. A real-time fluorescent quantitative PCR kit for the Chapparvovirus cat, which is characterized by comprising the primer for the real-time fluorescent quantitative PCR detection of the Chapparvovirus cat in claim 1.
3. The real-time fluorescent quantitative PCR kit of claim 2, wherein the real-time fluorescent quantitative PCR kit further comprises DNA fluorescent dye.
4. The real-time fluorescent quantitative PCR kit according to claim 3, wherein the DNA fluorescent dye is SYBR Green I.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111202886.4A CN113736923B (en) | 2021-10-15 | 2021-10-15 | Primer and kit for real-time fluorescent quantitative PCR (polymerase chain reaction) detection of Chapparvovirus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111202886.4A CN113736923B (en) | 2021-10-15 | 2021-10-15 | Primer and kit for real-time fluorescent quantitative PCR (polymerase chain reaction) detection of Chapparvovirus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113736923A CN113736923A (en) | 2021-12-03 |
CN113736923B true CN113736923B (en) | 2022-05-03 |
Family
ID=78726883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111202886.4A Active CN113736923B (en) | 2021-10-15 | 2021-10-15 | Primer and kit for real-time fluorescent quantitative PCR (polymerase chain reaction) detection of Chapparvovirus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113736923B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115725788A (en) * | 2022-09-06 | 2023-03-03 | 安徽农业大学 | Primer and TaqMan probe for detecting feline parvovirus and application thereof |
CN117305477B (en) * | 2023-11-27 | 2024-03-08 | 北京纳百生物科技有限公司 | Fluorescence detection kit for genotyping of cat blood group |
CN117487968B (en) * | 2024-01-03 | 2024-03-22 | 广东省农业科学院动物卫生研究所 | Primer and probe for detecting muscovy duck Cha Pama virus and virus separation culture method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112301157B (en) * | 2020-02-06 | 2024-03-22 | 广州普世君安生物科技有限公司 | RDA method and kit for rapidly detecting cat parvovirus (FPV) |
CN111893212A (en) * | 2020-06-17 | 2020-11-06 | 安徽农业大学 | Real-time fluorescence quantitative PCR (polymerase chain reaction) primer group and kit for feline infectious peritonitis virus |
CN111961756A (en) * | 2020-08-20 | 2020-11-20 | 中国农业科学院北京畜牧兽医研究所 | Primer, probe and detection kit for detecting feline panleukopenia virus |
CN112662822B (en) * | 2021-02-26 | 2022-06-14 | 甘肃农业大学 | Primer group, reagent and method for detecting feline parvovirus based on polymerase helix reaction |
AU2021103978A4 (en) * | 2021-07-08 | 2021-09-09 | Gansu Agricultural University | A primer set, reagent and method based on polymerase spiral reaction for detecting feline parvovirus |
-
2021
- 2021-10-15 CN CN202111202886.4A patent/CN113736923B/en active Active
Non-Patent Citations (1)
Title |
---|
establishment of SYBR green I-based quantitative real-time polymerase chain reaction for the rapid detection of a novel chaphamaparvovirus in cats;Xunbi Liu等;《biotech》;20220314;第12卷;文献号91 * |
Also Published As
Publication number | Publication date |
---|---|
CN113736923A (en) | 2021-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113736923B (en) | Primer and kit for real-time fluorescent quantitative PCR (polymerase chain reaction) detection of Chapparvovirus | |
CN108060269B (en) | DPO primer group for detecting porcine epidemic diarrhea virus, porcine transmissible gastroenteritis virus and porcine rotavirus and application thereof | |
CN112048570A (en) | PCR primer for detecting duck adenovirus type 4 and detection method and application thereof | |
CN113528708A (en) | Triple PCR detection method for simultaneously detecting three feline diarrhea viruses and application thereof | |
CN110819740A (en) | Digital PCR (polymerase chain reaction) kit for detecting carp edema virus | |
CN112063753A (en) | Locked nucleic acid modified primer pair, method and kit for detecting African swine fever virus | |
CN111534642A (en) | Reverse transcription-real-time fluorescence quantitative PCR kit for specifically detecting TWI (TWI-infectious bronchitis Virus) and application thereof | |
CN109234457A (en) | A kind of nano PCR method detecting Canine parvovirus infection | |
Wan et al. | Development of a restriction length polymorphism combined with direct PCR technique to differentiate goose and Muscovy duck parvoviruses | |
CN115725788A (en) | Primer and TaqMan probe for detecting feline parvovirus and application thereof | |
Yu et al. | TaqMan-probe-based multiplex real-time RT-qPCR for simultaneous detection of GoAstV, GPV, and GoCV | |
CN113897356B (en) | Fluorescent quantitative PCR (polymerase chain reaction) kit and primer for detecting chicken infectious anemia virus | |
CN112941240B (en) | Primer pair, kit and method for detecting goose astrovirus and goose goblet virus | |
CN111826473B (en) | Primer pair for fluorescent quantitative PCR detection of goose type 2 astrovirus and application thereof | |
AU2020103479A4 (en) | Primer set for detecting canine parvovirus and its application | |
Zou et al. | Development of a TaqMan-based multiplex real-time PCR for simultaneous detection of four feline diarrhea-associated viruses | |
CN111893218B (en) | Primer and probe for real-time fluorescent quantitative PCR detection of duck hepatitis C virus | |
CN114196786A (en) | Poultry adenovirus type 4 and 8 dual fluorescent quantitative PCR rapid detection kit and method | |
CN112646930A (en) | Primer pair, probe, kit and detection method for detecting porcine circovirus type 3 | |
CN108315480B (en) | Real-time fluorescent quantitative PCR primer, probe and kit for detecting tree shrew adenovirus | |
CN112063757A (en) | Primer and kit for detecting African swine fever virus and application of primer and kit | |
CN112522446A (en) | Detection primer pair and kit for wild strain of porcine pseudorabies virus | |
CN111172319A (en) | Primer pair for detecting porcine epidemic diarrhea virus, kit and application thereof | |
CN110885908A (en) | Real-time fluorescent quantitative RT-PCR detection method of norovirus | |
CN111500773A (en) | Fluorescent quantitative RT-PCR (reverse transcription-polymerase chain reaction) primer, probe and kit for identifying serotype of epidemic hemorrhagic disease virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |